Status:

TERMINATED

Sealed Therapeutic Shoe as Treatment of Diabetic Foot Ulcers

Lead Sponsor:

Region Örebro County

Collaborating Sponsors:

Forte

Conditions:

Diabetic Foot

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Total contact casts (TCCs) are effective treatment of plantar diabetic foot ulcers because they effectively offload the ulcer and are non-removable, resulting in high adherence to using the device. Ho...

Detailed Description

Data for the primary outcome of 112 participants are needed but the aim is to recruit 150, if possible within a reasonable time frame, to take drop-out into account. Participants are randomized (bloc...

Eligibility Criteria

Inclusion

  • Diagnosed with diabetes mellitus (any kind)
  • Foot ulcer under metatarsal heads

Exclusion

  • large ulcer (3-5 metatarsal heads)
  • critical ischemia (defined as toe pressure \<30 mmHg or TcPO2 \<30 mmHg)
  • uncontrolled infection (IWGDF infection grade 4, or grade 3 if not treatment against infection has been administered)
  • Active Charcot foot
  • foot deformities that necessitate custom-made shoes
  • inability to speak/read Swedish.
  • People with increased risk that side-effects will not be discovered or reported (dementia, abuse of alcohol or drugs, intellectual disability, etc.) if the person do not have appropriate social support, will be excluded.

Key Trial Info

Start Date :

January 16 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2022

Estimated Enrollment :

4 Patients enrolled

Trial Details

Trial ID

NCT04085926

Start Date

January 16 2020

End Date

February 1 2022

Last Update

May 31 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Mölndahls sjukhus

Gothenburg, Sweden, SE-431 80

2

Skånes Universitetssjukhus, Malmö

Malmo, Sweden, SE-205 02

3

Örebro Universitetssjukhus

Örebro, Sweden, SE-70185